{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:50:18Z","timestamp":1794613818438,"version":"4.9.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.clinthera.2022.04.012","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T10:55:14Z","timestamp":1653476114000},"page":"682-696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Nutrition as Therapy in Liver Disease"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0394-5168","authenticated-orcid":false,"given":"Neil D.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4200-3256","authenticated-orcid":false,"suffix":"IV","given":"Alfred Sidney","family":"Barritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2022.04.012_bib0001","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cgh.2011.08.016","article-title":"Prevalence and mechanisms of malnutrition inpatients with advanced liver disease, and nutrition management strategies","volume":"10","author":"Cheung","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0002","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Lai","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0003","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cld.2013.09.009","article-title":"The role of diet and nutritional intervention for the management of patients with NAFLD","volume":"18","author":"Barrera","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0004","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: A systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0005","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","article-title":"Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of randomised trials","volume":"55","author":"Musso","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0006","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss via lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0007","unstructured":"Malespin MH, Barritt ASt, Watkins SE, Schoen C, Tincopa MA, Corbin KD, Mospan AR, et\u00a0al. Weight loss and weight regain in usual clinical practice: results from the TARGET-NASH Observational Cohort [published online ahead of print January 21, 2021]. Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0008","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.clnu.2018.09.022","article-title":"Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses","volume":"38","author":"Ahn","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0009","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1053\/j.gastro.2009.01.048","article-title":"Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction","volume":"136","author":"Kirk","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0010","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/hep.24242","article-title":"Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects","volume":"53","author":"Haufe","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0011","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jada.2007.07.017","article-title":"Weight-loss outcomes: A systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up","volume":"107","author":"Franz","year":"2007","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0012","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/lt.21472","article-title":"Liver transplantation for sub-acute hepatocellular failure due to massive steatohepatitis after bariatric surgery","volume":"14","author":"D'Albuquerque","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0013","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO). \"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0014","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0015","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.clnu.2018.12.022","article-title":"ESPEN guideline on clinical nutrition in liver disease","volume":"38","author":"Plauth","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0016","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jhep.2012.02.023","article-title":"Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"57","author":"Keating","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0017","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2018.08.011","article-title":"Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease","volume":"69","author":"Wong","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0018","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jhep.2007.06.020","article-title":"Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study","volume":"47","author":"Zelber-Sagi","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0019","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jhep.2018.01.015","article-title":"High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance","volume":"68","author":"Zelber-Sagi","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0020","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/hep.30967","article-title":"Diet associations with nonalcoholic fatty liver disease in an ethnically diverse population: The Multiethnic Cohort","volume":"71","author":"Noureddin","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0021","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2147\/DMSO.S198744","article-title":"Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease","volume":"12","author":"Soleimani","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0022","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ajg.2013.95","article-title":"The Western dietary pattern is prospectively associated with nonalcoholic fatty liver disease in adolescence","volume":"108","author":"Oddy","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0023","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41575-021-00472-y","article-title":"Dietary carbohydrates and fats in nonalcoholic fatty liver disease","volume":"18","author":"Yki-J\u00e4rvinen","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0024","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/hep.23535","article-title":"Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease","volume":"51","author":"Abdelmalek","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jhep.2021.02.027","article-title":"Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial","volume":"75","author":"Geidl-Flueck","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0026","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/ajcn\/nqaa380","article-title":"Soft drink consumption and risk of nonalcoholic fatty liver disease: results from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study","volume":"113","author":"Zhang","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0027","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0041-1723751","article-title":"Effects of Mediterranean diet in patients with nonalcoholic fatty liver disease: A systematic review, meta-analysis, and meta-regression analysis of randomized controlled trials","volume":"41","author":"Kawaguchi","year":"2021","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0028","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1136\/gutjnl-2020-323106","article-title":"Effect of green-Mediterranean diet on intrahepatic fat: The DIRECT PLUS randomised controlled trial","volume":"70","author":"Yaskolka Meir","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0029","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/j.gastro.2020.11.051","article-title":"AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: Expert review","volume":"160","author":"Younossi","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cld.1172","article-title":"Intermittent fasting as a treatment for nonalcoholic fatty liver disease: What is the evidence?","volume":"19","author":"Memel","year":"2022","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0031","doi-asserted-by":"crossref","first-page":"11232","DOI":"10.1038\/s41598-019-47763-8","article-title":"A randomised controlled trial on the effectiveness and adherence of modified alternate-day calorie restriction in improving activity of non-alcoholic fatty liver disease","volume":"9","author":"Johari","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0032","article-title":"Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial","volume":"3","author":"Holmer","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0033","doi-asserted-by":"crossref","first-page":"13024","DOI":"10.1111\/obr.13024","article-title":"Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature","volume":"21","author":"Watanabe","year":"2020","journal-title":"Obes Rev"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0034","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3945\/ajcn.110.007674","article-title":"Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction","volume":"93","author":"Browning","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0035","first-page":"16855","article-title":"The role of vitamins in non-alcoholic fatty liver disease: A systematic review","volume":"13","author":"Abe","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0036","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0037","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jhep.2014.11.025","article-title":"Roles of alcohol consumption in fatty liver: A longitudinal study","volume":"62","author":"Moriya","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0038","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhep.2012.03.024","article-title":"Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"57","author":"Dunn","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0039","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/hep.30864","article-title":"Risks of light and moderate alcohol use in fatty liver disease: Follow-up of population cohorts","volume":"71","author":"\u00c5berg","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0040","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1186\/s12889-021-10991-7","article-title":"All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: A UK Biobank study","volume":"21","author":"Kennedy","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0041","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/liv.12304","article-title":"Impact of coffee on liver diseases: A systematic review","volume":"34","author":"Saab","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0042","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.3390\/nu13093042","article-title":"Effect of coffee consumption on non-alcoholic fatty liver disease incidence, prevalence and risk of significant liver fibrosis: Systematic review with meta-analysis of observational studies","volume":"13","author":"Ebadi","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0043","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cld.2012.08.009","article-title":"Nutrition in alcoholic liver disease","volume":"16","author":"Singal","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0044","first-page":"220","article-title":"Relationships between nutrition, alcohol use, and liver disease","volume":"27","author":"Lieber","year":"2003","journal-title":"Alcohol Res Health"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0045","first-page":"321","article-title":"Malabsorption in the chronic alcoholic","volume":"125","author":"Roggin","year":"1969","journal-title":"Johns Hopkins Med J"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0046","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0168-8278(00)80242-1","article-title":"Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease","volume":"32","author":"Parlesak","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0047","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/ajcn\/44.3.323","article-title":"Energy expenditure in chronic alcoholics with and without liver disease","volume":"44","author":"Jhangiani","year":"1986","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0048","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cgh.2016.08.047","article-title":"Medical management of severe alcoholic hepatitis: Expert review from the Clinical Practice Updates Committee of the AGA Institute","volume":"15","author":"Mitchell","year":"2017","journal-title":"Clin Gastroentrol Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0049","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1111\/liv.12798","article-title":"Nutritional therapy in cirrhosis or alcoholic hepatitis: A systematic review and meta-analysis","volume":"35","author":"Fialla","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0050","article-title":"Nutritional support for liver disease","volume":"2012","author":"Koretz","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0051","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2015.12.038","article-title":"Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids","volume":"150","author":"Moreno","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0052","series-title":"The ASPEN Adult Nutrition Support Core Curriculum","first-page":"532","article-title":"Liver Disease","author":"Medici","year":"2017"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0053","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.atherosclerosis.2006.11.036","article-title":"Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: A systematic review","volume":"194","author":"Sorokin","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0054","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1111\/j.1572-0241.2008.02092.x","article-title":"Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: A population-based cohort study","volume":"103","author":"Solaymani-Dodaran","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0055","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1111\/j.1572-0241.2001.04134.x","article-title":"Fat-soluble vitamin levels in patients with primary biliary cirrhosis","volume":"96","author":"JR","year":"2001","journal-title":"Am J Gastroentol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0056","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 Practice guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0057","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/cld.865","article-title":"Nutritional management of cholestasis","volume":"15","author":"Send","year":"2020","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0058","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0168-8278(01)00144-1","article-title":"Bone disease in primary biliary cirrhosis: independent indicators and rate of progression","volume":"35","author":"Menon","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0059","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.gastro.2010.10.014","article-title":"Bone disease in patients with primary sclerosing cholangitis","volume":"140","author":"Angulo","year":"2011","journal-title":"Gastroenterolgy"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0060","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/nu13020540","article-title":"Malnutrition in patients with liver cirrhosis","volume":"13","author":"Traub","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0061","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s10620-015-4015-z","article-title":"The Royal Free Hospital-Nutritional Prioritizing Tool is an independent predictor of deterioration of liver function and survival in cirrhosis","volume":"61","author":"Borhofen","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0062","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/hep.30828","article-title":"American expert opinion statement on sarcopenia in liver transplantation","volume":"70","author":"Carey","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0063","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hep.27830","article-title":"Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis","volume":"62","author":"Tapper","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0064","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jhep.2018.05.025","article-title":"Karnofsky performance status before and after liver transplantation predicts graft and patient survival","volume":"69","author":"Thuluvath","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0065","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.29219","article-title":"Development of a novel frailty index to predict mortality in patients with end-stage liver disease","volume":"66","author":"Lai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0066","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2020.03.029","article-title":"Changes in frailty are associated with waitlist mortality in patients with cirrhosis","volume":"73","author":"Lai","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0067","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5009\/gnl.2012.6.3.355","article-title":"Effect of a diet with unrestricted sodium on ascites in patients with hepatic cirrhosis","volume":"6","author":"Gu","year":"2012","journal-title":"Gut Liver"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0068","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1440-1746.2011.07043.x","article-title":"Preservation of nutritional-status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis","volume":"27","author":"Sorrentino","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0069","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.26370","article-title":"The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus","volume":"58","author":"Amodio","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0070","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cgh.2015.09.028","article-title":"Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial","volume":"14","author":"Maharshi","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0071","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jhep.2004.03.023","article-title":"Normal protein diet for episodic hepatic encephalopathy: results of a randomized study","volume":"41","author":"C\u00f3rdoba","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0072","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/BF01391449","article-title":"Treatment of chronic portal\u2014systemic encephalopathy with vegetable and animal protein diets: A controlled crossover study","volume":"27","author":"Uribe","year":"1982","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0073","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2796.1993.tb00689.x","article-title":"Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison","volume":"233","author":"Bianchi","year":"1993","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0074","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hep.22367","article-title":"Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: A randomized 12-month trial","volume":"48","author":"Plank","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0075","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1440-1746.2011.06951.x","article-title":"Late evening snack: exploiting a period of anabolic opportunity in cirrhosis","volume":"27","author":"Tsien","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0076","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jcsm.12039","article-title":"Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis","volume":"7","author":"Montano-Loza","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0077","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2169\/internalmedicine.55.5676","article-title":"Sarcopenia and sarcopenic obesity are prognostic factors for overall survival in patients with cirrhosis","volume":"55","author":"Hara","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0078","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2169\/internalmedicine.55.6298","article-title":"Sarcopenia and sarcopenic obesity are prognostic factors for overall survival in patients with cirrhosis","volume":"55","author":"Nishikawa","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0079","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.clnesp.2020.05.025","article-title":"A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity","volume":"38","author":"Kashiwagi","year":"2020","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0080","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/jgh.13166","article-title":"Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation","volume":"31","author":"Carias","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0081","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.24418","article-title":"Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis","volume":"54","author":"Berzigotti","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0082","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.28992","article-title":"Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study","volume":"65","author":"Berzigotti","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2022.04.012_bib0083","first-page":"45","article-title":"Feasibility of a high-PRotein Mediterranean-style diet and resistance Exercise in cardiac Rehabilitation patients with sarcopenic obesity (PRiMER): Study protocol for a randomised control trial","volume":"498","author":"McCullough","year":"2021","journal-title":"Clin Nutr ESPEN"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291822001515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291822001515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:57:07Z","timestamp":1758963427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291822001515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0149291822001515"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2022.04.012","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutrition as Therapy in Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2022.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}